BioGenCell
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
16 Divrey Chaim St, Netanya, 4244916, Is...Phone Number
+972 98609598Website
www.biogencell.netRevenue
$5.7 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About BioGenCell
BioGenCell is located at and has a strategic partnership with Laniado Hospital in Netanya, Israel. BioGenCell offers a patient- and clinician-centered platform that takes a standard blood draw in an outpatient setting with no need for pre-treatment, anesthesia, or hospitalization. Its patented, 24-hour process is rapid, biologically efficient, and employs a common/unified algorithm to create personalized medicine. Treatment requires only a single injection session in an outpatient setting and appears to have long-lasting effect.Explore more
BioGenCell Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioGenCell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at BioGenCell
Click to see if BioGenCell had a recent Job posting/layoffs
Check out if BioGenCell is spiking on competitors!
Product Launch: Get notified when BioGenCell launches new products
BioGenCell, which may be a good buyer, showed buying intent in Masked Content Topic
Check if BioGenCell has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on BioGenCell recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once BioGenCell has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
BioGenCell is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BioGenCell is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BioGenCell.
BioGenCell Tech Stack
A closer look at the technologies used by BioGenCell
See more technologies
BioGenCell News & Media
BioGenCell Announces the Launch of BioGenCell's Fifth Chronic Limb-Threatening Ischemia Clinical Trial Site in the United States
BioGenCell has announced the inauguration of the fifth Phase II cell-therapy-based clinical trial site for Chronic Limb-Threatening Ischemia (CLTI) in the United States at the University of Maryland Medical Center. This initiative is committed to dramatically reducing the incidence of...University of Maryland and BioGenCell Announce the Launch of BioGenCell Fifth Chronic Limb-Threatening Ischemia Clinical Trial Site in the United States
BioGenCell has announced the inauguration of the fifth Phase II cell-therapy-based clinical trial site for Chronic Limb-Threatening Ischemia (CLTI) in the United States at the University of Maryland, Baltimore. This initiative is committed to dramatically reducing the incidence of...Westchester Medical Center and BioGenCell Open BioGenCell's Fourth Chronic Limb-Threatening Ischemia Clinical Trial Site in the United States
Westchester Medical Center (an academic affiliate of Touro University/New York Medical College) and BioGenCell have marked a milestone with the opening of a Phase II cell-therapy based clinical trial site for Chronic Limb-Threatening Ischemia (CLTI) in the United States, following Yale...BioGenCell, developer of a unique platform for treating microvascular disease, has completed a $16 million seed round led by private investor Marius Nacht
NETANYA, Israel, May 9, 2022 /PRNewswire/ -- Israeli biotechnology company, BioGenCell, founded by Dr. Yael Porat and Prof. Michael Belkin, and developer of unique technology for using stem cells from the patient's own blood to treat microvascular diseases, has completed a $16 million...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioGenCell
Sign Up For FreeTo access detailed company insights
BioGenCell is located at and has a strategic partnership with Laniado Hospital in Netanya, Israel. BioGenCell offers a patient- and clinician-centered platform that takes a standard blood draw in an outpatient setting with no need for pre-treatment, anesthesia, or hospitalization. Its patented, 24-hour process is rapid, biologically efficient, and... Read More
